Von Miller Faces A Drug Suspension For Something Or Other
Broncos all-pro linebacker Von Miller faces a four-game suspension for violation of the league's drug policy. Except: it might be for a test he failed two years ago?
ESPN first reported the existence of the looming supension, and that Miller is appealing it. The that Miller failed tests for amphetamines and marijuana in his 2011 rookie season. But the Post uses wording that doesn't connect those failed tests to this suspension. So what happened?
The NFL's substance abuse policy is convoluted—a player who tests positive for a recreational drug enters a multi-tiered "intervention stage," with increased testing and a suspension coming down only after further positives. So Miller would have needed to get caught smoking weed again beyond his 2011 test.
But in 2007, the NFL reclassified amphetamines—previously recreational—as performance-enhancing drugs, meaning a single failed test is grounds for an immediate suspension. Either Miller successfully appealed his 2011 positive, or that original appeal is still ongoing. The wheels of NFL justice turn slowly, and on rare occasions quietly, but it'd be something remarkable if Miller is only now facing punishment for a drug test from two years ago.
It's entirely possible that this suspension is unrelated, and someone at the NFL leaked the info about the 2011 tests just to be a dick.
Miller appears to have just gotten word of the news:
Update: This narrows it down.
Michael Page’s UFC Exit Proves Winning Isn’t Always Enough
Mets vs. Yankees Subway Series Friday Betting Picks
- MLB Best Bets: Three Picks for Thursday’s Five-Game Slate
- Rams vs. 49ers Bet Prediction: Why Los Angeles Is the Pick in Australia
- MLB Wednesday Betting Picks: Cubs vs. Brewers, Aaron Judge and More
- Seahawks vs. Patriots Betting Pick for Super Bowl LX Rematch
- FIBA Women’s World Cup Picks: Back Team USA and Germany in Tuesday’s Action
- Dana White's Contender Series Week 5 Predictions and Picks
- Reds vs. Dodgers Prediction: Why the Dodgers Run Line Is Tuesday’s Best Bet

